Synthesis and characterization of heptacoordinated tin(IV) complexes. X-ray crystal structure of [nBu2Sn(dappt)]·(Me 2CO)0.5 [H2dappt = 2,6-diacetylpyridine bis(4-phenylthiosemicarbazone)]

As reações do ligante 2,6-diacetilpiridina bis(4-feniltiossemicarbazona), H2dappt, com R4-mSnXm (m = 2, 3; R = Me, nBu, Ph e X = Cl) resultaram na formação de quatro novos complexos organoestânicos heptacoordenados, os quais foram caracterizados por análise elementar e pelas espectroscopias no IV e Mössbauer. O derivado n-butila, [nBu2Sn(dappt)]·(Me 2CO)0.5, foi também analisado por um estudo de difração de raios X em um monocristal. O complexo cristalizou-se no sistema monoclínico e grupo espacial C2/c, com a = 36,164(14), b = 9,7050(15), c = 26,194(11) Å, beta = 132,00(2)º, Z = 8. A determinação da estrutura revelou um complexo neutro de Sn(IV), numa geometria bipiramidal pentagonal (BPP), com o plano equatoral definido pelos átomos doadores SNNNS do ligante e dois grupos n-bultila nas posições axiais. Também é discutida uma correlação entre os dados de Mössbauer e de difração de raios X, baseada no modelo da carga-pontual.The reactions of the 2,6-diacetylpyridine bis(4-phenylthiosemicarbazone) ligand, H2dappt, with R4-mSnXm (m = 2, 3; R = Me, nBu, Ph and X = Cl) led to the formation of four new heptacoordinated organotin(IV) complexes, which were characterized by microanalyses and by IR and Mössbauer spectroscopies. The n-butyl derivative [nBu2Sn(dappt)]·(Me 2CO)0.5 was also analyzed by a single crystal X-ray diffraction study. It crystallized in the monoclinic system with a space group C2/c, with a = 36.164(14), b = 9.7050(15), c = 26.194(11) Å, beta = 132.00(2)º, Z = 8. The structure determination revealed a neutral complex of Sn(IV) in a distorted pentagonal bipyramidal (PBP) geometry, with the equatorial plane defined by the SNNNS donor system of the ligand and with the two n-butyl groups in the axial positions. Also, a correlation between Mössbauer and X-ray data based on the point-charge model is discussed.The reactions of the 2,6-diacetylpyridine bis(4-phenylthiosemicarbazone) ligand, H2dappt, with R4-mSnXm (m = 2, 3; R = Me, nBu, Ph and X = Cl) led to the formation of four new heptacoordinated organotin(IV) complexes, which were characterized by microanalyses and by IR and Mössbauer spectroscopies. The n-butyl derivative [nBu2Sn(dappt)]·(Me 2CO)0.5 was also analyzed by a single crystal X-ray diffraction study. It crystallized in the monoclinic system with a space group C2/c, with a = 36.164(14), b = 9.7050(15), c = 26.194(11) Å, beta = 132.00(2)º, Z = 8. The structure determination revealed a neutral complex of Sn(IV) in a distorted pentagonal bipyramidal (PBP) geometry, with the equatorial plane defined by the SNNNS donor system of the ligand and with the two n-butyl groups in the axial positions. Also, a correlation between Mössbauer and X-ray data based on the point-charge model is discussed

Synthesis and characterization of heptacoordinated tin(IV) complexes. X-ray crystal structure of [nBu2Sn(dappt)]·(Me 2CO)0.5 [H2dappt = 2,6-diacetylpyridine bis(4-phenylthiosemicarbazone)]

The reactions of the 2,6-diacetylpyridine bis(4-phenylthiosemicarbazone) ligand, H2dappt, with R4-mSnXm (m = 2, 3; R = Me, nBu, Ph and X = Cl) led to the formation of four new heptacoordinated organotin(IV) complexes, which were characterized by microanalyses and by IR and Mössbauer spectroscopies. The n-butyl derivative [nBu2Sn(dappt)]·(Me 2CO)0.5 was also analyzed by a single crystal X-ray diffraction study. It crystallized in the monoclinic system with a space group C2/c, with a = 36.164(14), b = 9.7050(15), c = 26.194(11) Å, beta = 132.00(2)º, Z = 8. The structure determination revealed a neutral complex of Sn(IV) in a distorted pentagonal bipyramidal (PBP) geometry, with the equatorial plane defined by the SNNNS donor system of the ligand and with the two n-butyl groups in the axial positions. Also, a correlation between Mössbauer and X-ray data based on the point-charge model is discussed

Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity

The development of more efficient anti-tuberculosis drugs is of interest. Three oxovanadium(IV) and three cis-dioxovanadium(V) complexes with thiosemicarbazone derivatives bearing moieties with different lipophilicity have been prepared and had their inhibitory activity against Mycobacterium tuberculosis H(37)Rv ATCC 27294 evaluated. The analytical methods used by the complexes` characterization included IR, EPR, (1)H, (13)C and (51)V NMR spectroscopies, elemental analysis, cyclic voltammetry, magnetic susceptibility measurement and single crystal X-ray diffractometry. [VO(acac)(aptsc)], [VO(acac)(apmtsc)] and [VO(acac)(apptsc)] (acac = acetylacetonate; Haptsc = 2-acetylpyridinethiosemicarbazone; Hapmtsc = 2-acetylpyridine-N(4)-methyl-thiosemicarbazone and Happtsc = 2-acetylpyridine-N(4)-phenyl-thiosemicarbazone) are paramagnetic and their EPR spectra are consistent with the monoanionic N,N,S-tridentate coordination of the thiosemicarbazone ligands, resulting in octahedral structures of rhombic symmetry and with the oxidation state +IV for the vanadium atom. As result of oxidation of the vanadium(IV) complexes above, the diamagnetic cis-dioxovanadium(V) complexes [VO(2)(aptsc)[, [VO(2)(apmtsc)[ and [VO(2)(apptsc)] are formed. Their (1)H, (13)C and (51)V NMR spectra were acquired and support a distorted square pyramidal geometry for them, in accord with the solid state X-ray structures determined for [VO(2)(aptsc)] and [VO(2)(apmtsc)]. In general, the vanadium compounds show comparable or larger anti-M. tuberculosis activities than the free thiosemicarbazone ligands, with MIC values within 62.5-1.56 (mu g/mL). (C) 2008 Elsevier Ltd. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAPESPConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)PRONEX/FAPESP[03/09859-2]Financiadora de Estudos e Projetos (FINEP)FINEP[0970/01]CNPqConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)CAPESCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES